The Disposable Hypodermic Needle Market size was valued at USD 5,430.00 million in 2018 to USD 6,306.76 million in 2024 and is anticipated to reach USD 9,539.97 million by 2032, at a CAGR of 5.38% during the forecast period.
REPORT ATTRIBUTE
DETAILS
Historical Period
2020-2023
Base Year
2024
Forecast Period
2025-2032
Disposable Hypodermic Needle Market Size 2024
USD 6,306.76 Million
Disposable Hypodermic Needle Market, CAGR
5.38%
Disposable Hypodermic Needle Market Size 2032
USD 9,539.97 Million
The market growth is driven by rising demand for safe and efficient medical procedures, supported by increasing hospital admissions and surgical volumes. Growing awareness of infection control practices and regulatory emphasis on single-use medical devices enhance adoption. Advancements in needle design, including safety-engineered features, reduce accidental injuries and improve patient compliance. Additionally, expanding healthcare infrastructure in developing regions contributes significantly to wider availability and increased usage of disposable hypodermic needles.
Geographically, North America leads due to advanced healthcare systems, high procedure volumes, and strong regulatory frameworks promoting patient safety. Europe maintains a solid presence, supported by established medical infrastructure and strict infection control policies. Asia-Pacific emerges as the fastest-growing region, fueled by rising healthcare investments, population growth, and increasing awareness of hygiene standards. Latin America and the Middle East also show gradual adoption, driven by improved access to healthcare services.
Market Insights:
The Disposable Hypodermic Needle Market was valued at USD 5,430.00 million in 2018, reached USD 6,306.76 million in 2024, and is projected to hit USD 9,539.97 million by 2032, registering a CAGR of 5.38%.
North America held 37.97% of the market in 2024, driven by advanced healthcare infrastructure and high procedure volumes; Europe followed with 22.58%, supported by strong regulations; Asia Pacific captured 26.22%, backed by large populations and expanding healthcare access.
Asia Pacific is the fastest-growing region with a 26.22% share in 2024, fueled by rising chronic disease prevalence, mass vaccination programs, and increased healthcare investments.
Syringe needles represented the largest segment in 2024 with 32% share, dominating routine hospital and clinic procedures.
Safety needles accounted for 27% share in 2024, supported by regulatory push and rising adoption of injury-prevention devices.
Access crucial information at unmatched prices!
Request your sample report today & start making informed decisions powered by Credence Research Inc.!
Rising Demand from Expanding Healthcare Infrastructure and Surgical Interventions
The Disposable Hypodermic Needle Market benefits from growing hospital admissions and surgical interventions worldwide. A consistent rise in chronic disease prevalence increases the number of injections required for patient treatment. The rising global burden of diabetes, cardiovascular conditions, and cancer supports higher needle consumption. Governments are expanding healthcare budgets, leading to greater accessibility of essential medical supplies. It has become essential for hospitals and clinics to rely on safe, sterile disposable options to minimize risks. Regulatory bodies across regions mandate single-use devices to prevent cross-contamination. The alignment of clinical practices with strict patient safety protocols pushes adoption further. Rising emphasis on infection control elevates disposable hypodermic needles into a necessary standard in healthcare.
For instance, in August 2025, Becton, Dickinson and Company (BD) invested over $35 million to expand its Columbus, Nebraska facility, boosting annual US production capacity of BD PosiFlush™ prefilled flush syringes above 750 million units to meet growing hospital demand.
Increased Focus on Infection Prevention and Patient Safety Enhancing Product Demand
Healthcare providers recognize that reusable devices contribute significantly to infection spread. The Disposable Hypodermic Needle Market responds with strong adoption in hospitals and ambulatory care centers. Infection control policies highlight disposable devices as critical to maintaining safe medical environments. The growth of surgical centers, vaccination programs, and outpatient services reinforces the demand base. It is becoming clear that disposable designs lower the incidence of accidental injuries for healthcare workers. Needle-stick injury reduction remains an essential factor driving product demand. Safety-engineered designs receive backing from international health organizations and local regulatory authorities. Patient-centric approaches prioritize reliable disposable equipment, driving further procurement across healthcare facilities.
Technological Developments in Safety-Engineered Designs Increasing Market Adoption
Manufacturers innovate by introducing safety shields, retractable tips, and ergonomic designs to protect users. The Disposable Hypodermic Needle Market witnesses accelerated acceptance of these advanced designs across hospitals. Such innovations directly address occupational hazards that healthcare professionals face daily. Safety-engineered products gain regulatory preference, prompting broader procurement in both developed and emerging markets. It remains vital for medical systems to invest in designs that minimize human error and enhance usability. Hospitals and clinics consider these devices essential for compliance with modern safety standards. New product launches highlight improvements in ease of handling and reduction of disposal hazards. Growing awareness among professionals makes safety-based innovations a defining driver of market expansion.
Strong Governmental and Institutional Support for Single-Use Medical Devices
Government agencies and healthcare institutions prioritize single-use equipment for public health security. The Disposable Hypodermic Needle Market aligns with international campaigns promoting sterile, disposable medical devices. It is strongly influenced by vaccine distribution programs that rely on safe delivery systems. Emerging economies strengthen their procurement systems to meet rising demand for mass immunization programs. Public-private partnerships accelerate the supply of disposable devices across underserved regions. Global health agencies encourage bulk purchases to standardize needle use in treatment programs. Healthcare policies create favorable environments for manufacturers focusing on disposable categories. Institutional frameworks make disposable hypodermic needles indispensable for achieving healthcare safety objectives.
For instance, Hindustan Syringes & Medical Devices (HMD) supplied over 400 million low dead space syringes to the Indian government for COVID-19 inoculation and delivered additional orders to Japan, UNICEF, and Brazil in 2021, as confirmed by HMD’s leadership and international news sources.HMD’s New Delhi plants increased total annual syringe output to 2.5 billion units in response to global mass immunization demand.
Market Trends:
Growing Integration of Eco-Friendly and Sustainable Needle Disposal Solutions
Environmental impact concerns push innovation in eco-friendly designs and waste management. The Disposable Hypodermic Needle Market observes rising use of biodegradable or recyclable materials. Hospitals implement safer and greener disposal systems to reduce hazardous medical waste. It is essential for healthcare providers to balance infection safety with environmental responsibility. Manufacturers seek certifications for sustainable products, raising their acceptance across global markets. Regulatory bodies encourage environmentally sound disposal practices, creating opportunities for compliant suppliers. Healthcare systems in developed regions focus on advanced incineration or sterilization methods. Adoption of eco-responsible practices forms a significant trend shaping product development strategies.
For instance, in the first half of 2023, Becton Dickinson (BD) and Casella Waste Systems completed an industry-first pilot that successfully recycled 40,000 pounds of medical waste from used syringes and needles collected from U.S. healthcare facilities.
Rising Demand from Homecare and Self-Administration of Injections
The shift toward homecare and self-administration creates new opportunities for market players. The Disposable Hypodermic Needle Market addresses demand from diabetic patients requiring frequent injections. Rising prevalence of chronic diseases leads patients to prefer convenient self-use devices. It has become essential for manufacturers to design user-friendly, safe, and ergonomic products. Growing telehealth adoption supports delivery of injectable therapies outside hospital settings. Retail pharmacies and online platforms emerge as key distribution channels for disposable devices. Elderly populations embrace self-administered injections for long-term treatments under medical guidance. This trend enhances accessibility and strengthens recurring demand across household healthcare segments.
Increasing Penetration of Digital Supply Chains and E-Commerce Platforms
Supply chain modernization supports fast delivery and wider accessibility of disposable devices. The Disposable Hypodermic Needle Market benefits from integration with advanced distribution networks. It is now common for hospitals and clinics to procure through digital platforms. Online procurement channels enable competitive pricing and timely availability of bulk supplies. E-commerce channels expand product reach to rural and semi-urban regions. Global distributors invest in smarter logistics to ensure uninterrupted supply to healthcare facilities. Manufacturers establish partnerships with third-party logistics providers to strengthen market presence. This digital transformation forms a strong trend in the distribution and accessibility model.
Customization and Differentiation in Needle Designs Based on Applications
Manufacturers focus on specialized product designs tailored for specific therapeutic uses. The Disposable Hypodermic Needle Market includes variants designed for vaccines, insulin, and oncology. It is necessary to provide unique specifications to ensure safety and efficacy in various applications. Needle gauges, lengths, and safety features vary depending on clinical requirements. Healthcare providers seek specialized devices to meet diverse patient and treatment needs. Customization supports patient comfort and compliance, raising overall treatment satisfaction. Continuous innovation in product variety creates competitive differentiation in global markets. This trend highlights growing demand for targeted and specialized medical solutions.
For instance, in January 2025, Terumo launched its Injection Filter Needle as part of the INFINO™ Development Program, integrating a 5-micrometer mesh filter and a thin-walled design to enhance flow rate and safety during hypodermic and intravitreal injections; this was confirmed by Terumo’s global press release and official product information.
Market Challenges Analysis:
High Manufacturing Costs and Supply Chain Pressure Restricting Wider Market Penetration
The Disposable Hypodermic Needle Market faces challenges linked to rising raw material costs and complex manufacturing. It requires significant investments to produce safe and high-quality disposable devices. Limited availability of cost-effective supply chains in emerging economies creates barriers. It has become difficult for smaller firms to compete with established global manufacturers. Fluctuations in raw material pricing disrupt consistent production strategies. Manufacturing costs rise due to safety-engineered design requirements mandated by regulatory authorities. Healthcare facilities in low-income countries find these costs restrictive for bulk adoption. This limits accessibility and slows down uniform penetration across all regions.
Environmental Burden and Disposal Concerns Hindering Global Growth
The Disposable Hypodermic Needle Market experiences major challenges from waste management and environmental impact. Disposable products generate large volumes of hazardous medical waste needing careful treatment. It is increasingly difficult for healthcare systems to balance safety and sustainability. Regions with limited infrastructure struggle to dispose of contaminated devices safely. Strict environmental regulations raise compliance costs for both manufacturers and providers. Hospitals face rising operational expenses linked to safe disposal requirements. Growing environmental awareness pressures companies to adopt greener alternatives despite higher costs. These concerns act as significant restraints to overall market expansion.
Market Opportunities:
Expanding Demand from Emerging Healthcare Markets and Strengthening Institutional Investments
Emerging economies provide strong growth prospects with expanding healthcare access and infrastructure. The Disposable Hypodermic Needle Market gains opportunities from rising medical tourism and public health programs. It benefits from institutional investments that focus on safe medical practices. Governments in Asia, Latin America, and Africa invest heavily in hospital networks. It is evident that rapid urbanization and disease prevalence create sustained demand for disposable devices. International aid programs also fund bulk procurement to support healthcare reforms. Market participants have the chance to strengthen presence in these developing regions. Long-term opportunities emerge from rising treatment volumes and consistent supply requirements.
Development of Advanced Product Features Creating Long-Term Market Differentiation
Innovation in product features creates valuable growth opportunities for manufacturers. The Disposable Hypodermic Needle Market benefits from demand for user-friendly, ergonomic, and safer devices. It is now essential to integrate retractable tips and automated safety locks. These advanced features build trust among healthcare professionals and patients. Hospitals prefer products that ensure safety, compliance, and operational efficiency. Manufacturers can leverage product differentiation to secure strong competitive positions. Rising demand for patient-centered designs enhances innovation potential. Long-term opportunity lies in consistent evolution of features that meet global safety standards.
Market Segmentation Analysis:
The Disposable Hypodermic Needle Market is segmented
By type into safety needles, standard needles, insulin needles, vacutainer needles, and syringe needles. Safety needles are gaining traction due to their role in preventing accidental injuries among healthcare workers. Standard needles maintain consistent demand in hospitals and clinics because of their affordability and wide availability. Insulin needles are witnessing strong growth, supported by the rising prevalence of diabetes worldwide. Vacutainer needles remain essential in diagnostic settings, while syringe needles continue to dominate in routine medical use.
For example, Nipro manufactures over 11 billion standard hypodermic needles annually, with a global distribution in hospitals and clinics. Their ultra-sharp, tri-beveled, siliconized needles minimize patient discomfort and are sterilized for mass clinical use.
By material, stainless steel dominates due to its strength, durability, and sterilization compatibility. Plastic variants support cost efficiency and broader accessibility across emerging markets. Coated needles improve patient comfort and enhance safety features, encouraging adoption in advanced healthcare settings. Glass-based needles remain limited but find use in specialized clinical applications requiring precision.
By end-user industries, hospitals lead due to high patient volumes and surgical procedures. Diagnostic laboratories rely on disposable options to ensure accuracy in testing environments. Home healthcare settings record growth from chronic disease patients requiring regular injections. Pharmaceutical companies contribute through demand for clinical trials and drug delivery. Clinics and physician offices strengthen the base through recurring daily usage.
For example, BD Eclipse™ and SafetyGlide™ safety needles are deployed across U.S. and European hospital networks to comply with workplace safety mandates and surgical volume needs.
By application, vaccination and insulin delivery are primary growth contributors, while intravenous therapy and surgical procedures represent critical hospital-driven demand. Diagnostic procedures expand use in laboratory and outpatient environments.
By distribution channels are diverse, with direct sales and wholesale distributors serving hospitals, while retail pharmacies, online platforms, and medical supply stores enhance patient accessibility.
Segmentation:
By Type
Safety Needles
Standard Needles
Insulin Needles
Vacutainer Needles
Syringe Needles
ByMaterial
Stainless Steel
Plastic
Coated Needles
Glass
By End-User Industry
Hospitals
Diagnostic Laboratories
Home Healthcare Settings
Pharmaceutical Companies
Clinics and Physician Offices
By Application
Vaccination
Insulin Delivery
Intravenous (IV) Therapy
Surgical Procedures
Diagnostic Procedures
By Distribution Channel
Direct Sales
Retail Pharmacies
Online Sales
Wholesale Distributors
Medical Supply Stores
By Regions
North America
U.S.
Canada
Mexico
Europe
UK
France
Germany
Italy
Spain
Russia
Belgium
Netherlands
Austria
Sweden
Poland
Denmark
Switzerland
Rest of Europe
Asia Pacific
China
Japan
South Korea
India
Australia
Thailand
Indonesia
Vietnam
Malaysia
Philippines
Taiwan
Rest of Asia Pacific
Latin America
Brazil
Argentina
Peru
Chile
Colombia
Rest of Latin America
Middle East
UAE
KSA
Israel
Turkey
Iran
Rest of Middle East
Africa
Egypt
Nigeria
Algeria
Morocco
Rest of Africa
Regional Analysis:
North America
The North America Disposable Hypodermic Needle Market size was valued at USD 2,085.12 million in 2018 to USD 2,394.01 million in 2024 and is anticipated to reach USD 3,616.62 million by 2032, at a CAGR of 5.4% during the forecast period. North America accounts for 37.97% of the global share in 2024, making it the largest regional market. The market is driven by advanced healthcare infrastructure, high procedure volumes, and widespread adoption of safety-engineered devices. It benefits from strong regulatory frameworks that prioritize infection prevention and occupational safety. Government-backed vaccination programs and chronic disease management initiatives sustain high demand. Hospitals and clinics dominate usage, while home healthcare expands through insulin delivery and long-term care applications. The presence of global manufacturers strengthens supply availability across the U.S., Canada, and Mexico. It continues to lead through innovation adoption and regulatory alignment with stringent healthcare standards.
Europe
The Europe Disposable Hypodermic Needle Market size was valued at USD 1,281.48 million in 2018 to USD 1,423.89 million in 2024 and is anticipated to reach USD 2,020.11 million by 2032, at a CAGR of 4.6% during the forecast period. Europe represents 22.58% of the global market in 2024, positioning it as the second-largest region. Strong emphasis on infection control, patient safety, and regulatory compliance drives consistent adoption. It benefits from well-established healthcare systems in Germany, France, and the UK. Rising investments in outpatient care and diagnostic laboratories add momentum to demand. Safety needles gain preference across European hospitals to reduce accidental injuries. Pharmaceutical companies in the region contribute through consistent trial-related consumption. Expansion of universal healthcare coverage in Eastern Europe provides new growth opportunities. It maintains steady performance with growing emphasis on sustainable healthcare practices.
Asia Pacific
The Asia Pacific Disposable Hypodermic Needle Market size was valued at USD 1,362.93 million in 2018 to USD 1,651.40 million in 2024 and is anticipated to reach USD 2,750.38 million by 2032, at a CAGR of 6.6% during the forecast period. Asia Pacific holds 26.22% of the global market in 2024, emerging as the fastest-growing region. The market benefits from expanding healthcare infrastructure, rising population, and increasing burden of chronic diseases. It gains momentum from government-backed vaccination programs in China, India, and Southeast Asia. Growing urbanization enhances demand for advanced medical facilities and equipment. Home healthcare adoption rises in Japan and South Korea due to aging populations. Local manufacturing bases support cost efficiency and supply availability. The region continues to attract multinational companies investing in scalable production and distribution. It remains a vital hub for long-term growth through demographic expansion and healthcare modernization.
Latin America
The Latin America Disposable Hypodermic Needle Market size was valued at USD 282.36 million in 2018 to USD 324.10 million in 2024 and is anticipated to reach USD 447.14 million by 2032, at a CAGR of 4.2% during the forecast period. Latin America accounts for 5.14% of the global market in 2024, reflecting steady but moderate growth. It benefits from improving healthcare access and rising government focus on immunization programs. Brazil dominates regional demand due to large-scale hospital infrastructure and a growing private healthcare sector. Argentina and other emerging countries strengthen adoption through public health reforms. It faces challenges in affordability and procurement efficiency in rural areas. Growth is supported by expanding diagnostic services and pharmaceutical company investments. Online sales and retail pharmacies are emerging as vital distribution channels. It continues to evolve with rising awareness of infection prevention and safety practices.
Middle East
The Middle East Disposable Hypodermic Needle Market size was valued at USD 276.93 million in 2018 to USD 306.47 million in 2024 and is anticipated to reach USD 430.31 million by 2032, at a CAGR of 4.4% during the forecast period. The Middle East represents 4.87% of the global share in 2024, driven by growing hospital infrastructure and medical tourism. It benefits from large-scale government investments in healthcare modernization. GCC countries remain the core markets due to high procedure volumes and strong public-private partnerships. Israel and Turkey contribute significantly through advanced medical technology adoption. It faces constraints from uneven access in rural and underserved areas. Hospitals dominate demand, while diagnostic laboratories strengthen their procurement activities. Rising prevalence of chronic diseases fuels consistent usage across multiple applications. It shows stable growth with opportunities tied to ongoing healthcare reforms and technology upgrades.
Africa
The Africa Disposable Hypodermic Needle Market size was valued at USD 141.18 million in 2018 to USD 206.89 million in 2024 and is anticipated to reach USD 275.41 million by 2032, at a CAGR of 3.3% during the forecast period. Africa holds 3.17% of the global market in 2024, making it the smallest regional contributor. The market is supported by international aid programs that fund vaccination and essential healthcare delivery. South Africa leads in regional demand due to better hospital infrastructure and private healthcare growth. Egypt contributes strongly through expansion in urban medical facilities. It faces challenges from limited healthcare access and inconsistent procurement in remote regions. Rising awareness of hygiene and infection prevention creates new opportunities. Local distribution networks and retail pharmacies are gaining importance in accessibility. It continues to grow gradually, supported by international partnerships and healthcare reforms.
Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!
The Disposable Hypodermic Needle Market is characterized by the presence of established multinational corporations and regional manufacturers competing across pricing, innovation, and distribution strength. Leading players focus on safety-engineered products, expanding product portfolios, and maintaining compliance with stringent healthcare regulations. It is driven by continuous product innovation aimed at minimizing needle-stick injuries and improving patient comfort. Companies invest in strategic mergers, acquisitions, and regional expansions to strengthen their global footprint. Competitive intensity remains high due to growing demand from hospitals, diagnostic laboratories, and home healthcare settings. Emerging players leverage cost-efficient production and localized distribution networks to penetrate developing markets. It also reflects increasing adoption of e-commerce and digital procurement channels, pushing companies to modernize their supply strategies. Global and regional firms strive to balance affordability, safety, and sustainability, positioning themselves as reliable suppliers in a market defined by regulatory alignment and evolving healthcare needs.
Recent Developments:
In January 2025, Terumo Corporation launched the Injection Filter Needle under its INFINO™ development program. This needle, designed for both hypodermic and intravitreal applications, includes a 5-micrometer polyamide mesh filter to prevent particle contamination and features a thin-walled cannula for enhanced safety during sensitive injections.
Report Coverage:
The research report offers an in-depth analysis based on Type, Material, End-User Industry, Application and Distribution Channel. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.
Future Outlook:
The Disposable Hypodermic Needle Market will expand steadily, supported by rising surgical procedures worldwide.
Growing adoption of safety-engineered devices will strengthen market share across hospitals and clinics.
Rising chronic disease prevalence will drive demand for insulin and intravenous therapy applications.
Technological advancements in coated and ergonomic designs will enhance patient safety and compliance.
Expanding healthcare infrastructure in developing economies will open new opportunities for suppliers.
Regulatory pressure for single-use devices will ensure long-term demand consistency.
Online platforms and digital procurement models will reshape global distribution strategies.
Pharmaceutical industry growth and clinical trials will sustain demand for high-volume needle use.
Environmental sustainability will encourage innovations in eco-friendly materials and disposal practices.
Strategic partnerships and regional expansions will define competition in emerging markets.
CHAPTER NO. 1 : GENESIS OF THE MARKET
1.1 Market Prelude – Introduction & Scope
1.2 The Big Picture – Objectives & Vision
1.3 Strategic Edge – Unique Value Proposition
1.4 Stakeholder Compass – Key Beneficiaries CHAPTER NO. 2 : EXECUTIVE LENS
2.1 Pulse of the Industry – Market Snapshot
2.2 Growth Arc – Revenue Projections (USD Million)
2.3. Premium Insights – Based on Primary Interviews CHAPTER NO. 3 : DISPOSABLE HYPODERMIC NEEDLE MARKET FORCES & INDUSTRY PULSE
3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown
3.6 Price Trend Analysis
3.6.1 Regional Price Trend
3.6.2 Price Trend by product CHAPTER NO. 4 : KEY INVESTMENT EPICENTER
4.1 Regional Goldmines – High-Growth Geographies
4.2 Product Frontiers – Lucrative Product Categories
4.3 Material Sweet Spots – Emerging Demand Segments CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING
5.1 Momentum Metrics – Forecast & Growth Curves
5.2 Regional Revenue Footprint – Market Share Insights
5.3 Segmental Wealth Flow – Type & Material Revenue CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS
6.1. Import Analysis by Region
6.1.1. Global Disposable Hypodermic Needle Market Import Revenue By Region
6.2. Export Analysis by Region
6.2.1. Global Disposable Hypodermic Needle Market Export Revenue By Region CHAPTER NO. 7 : COMPETITION ANALYSIS
7.1. Company Market Share Analysis
7.1.1. Global Disposable Hypodermic Needle Market: Company Market Share
7.2. Global Disposable Hypodermic Needle Market Company Revenue Market Share
7.3. Strategic Developments
7.3.1. Acquisitions & Mergers
7.3.2. New Product Launch
7.3.3. Regional Expansion
7.4. Competitive Dashboard
7.5. Company Assessment Metrics, 2024 CHAPTER NO. 8 : DISPOSABLE HYPODERMIC NEEDLE MARKET – BY TYPE SEGMENT ANALYSIS
8.1. Disposable Hypodermic Needle Market Overview by Type Segment
8.1.1. Disposable Hypodermic Needle Market Revenue Share By Type
8.2. Safety Needles
8.3. Standard Needles
8.4. Insulin Needles
8.5. Vacutainer Needles
8.6. Syringe Needles CHAPTER NO. 9 : DISPOSABLE HYPODERMIC NEEDLE MARKET – BY MATERIAL SEGMENT ANALYSIS
9.1. Disposable Hypodermic Needle Market Overview by Material Segment
9.1.1. Disposable Hypodermic Needle Market Revenue Share By Material
9.2. Stainless Steel
9.3. Plastic
9.4. Coated Needles
9.5. Glass CHAPTER NO. 10 : DISPOSABLE HYPODERMIC NEEDLE MARKET – BY END-USER INDUSTRY SEGMENT ANALYSIS
10.1. Disposable Hypodermic Needle Market Overview by End-user Industry Segment
10.1.1. Disposable Hypodermic Needle Market Revenue Share By End-user Industry
10.2. Hospitals
10.3. Diagnostic Laboratories
10.4. Home Healthcare Settings
10.5. Pharmaceutical Companies
10.6. Clinics and Physician Offices CHAPTER NO. 11 : DISPOSABLE HYPODERMIC NEEDLE MARKET – BY APPLICATION SEGMENT ANALYSIS
11.1. Disposable Hypodermic Needle Market Overview by Application Segment
11.1.1. Disposable Hypodermic Needle Market Revenue Share By Application
11.2. Vaccination
11.3. Insulin Delivery
11.4. Intravenous (IV) Therapy
11.5. Surgical Procedures
11.6. Diagnostic Procedures CHAPTER NO. 12 : DISPOSABLE HYPODERMIC NEEDLE MARKET – BY DISTRIBUTION CHANNEL SEGMENT ANALYSIS
12.1. Disposable Hypodermic Needle Market Overview by Distribution Channel Segment
12.1.1. Disposable Hypodermic Needle Market Revenue Share By Distribution Channel
12.2. Direct Sales
12.3. Retail Pharmacies
12.4. Online Sales
12.5. Wholesale Distributors
12.6. Medical Supply Stores CHAPTER NO. 13 : DISPOSABLE HYPODERMIC NEEDLE MARKET – REGIONAL ANALYSIS
13.1. Disposable Hypodermic Needle Market Overview by Region Segment
13.1.1. Global Disposable Hypodermic Needle Market Revenue Share By Region
13.1.2. Regions
13.1.3. Global Disposable Hypodermic Needle Market Revenue By Region
13.1.4. Type
13.1.5. Global Disposable Hypodermic Needle Market Revenue By Type
13.1.6. Material
13.1.7. Global Disposable Hypodermic Needle Market Revenue By Material
13.1.8. End-user Industry
13.1.9. Global Disposable Hypodermic Needle Market Revenue By End-user Industry
13.1.10. Application
13.1.12. Global Disposable Hypodermic Needle Market Revenue By Application
13.1.13. Distribution Channel
13.1.14. Global Disposable Hypodermic Needle Market Revenue By Distribution Channel CHAPTER NO. 14 : NORTH AMERICA DISPOSABLE HYPODERMIC NEEDLE MARKET – COUNTRY ANALYSIS
14.1. North America Disposable Hypodermic Needle Market Overview by Country Segment
14.1.1. North America Disposable Hypodermic Needle Market Revenue Share By Region
14.2. North America
14.2.1. North America Disposable Hypodermic Needle Market Revenue By Country
14.2.2. Type
14.2.3. North America Disposable Hypodermic Needle Market Revenue By Type
14.2.4. Material
14.2.5. North America Disposable Hypodermic Needle Market Revenue By Material
14.2.6. End-user Industry
14.2.7. North America Disposable Hypodermic Needle Market Revenue By End-user Industry
14.2.8. Application
14.2.9. North America Disposable Hypodermic Needle Market Revenue By Application
14.2.10. Distribution Channel
14.2.11. North America Disposable Hypodermic Needle Market Revenue By Distribution Channel
14.3. U.S.
14.4. Canada
14.5. Mexico CHAPTER NO. 15 : EUROPE DISPOSABLE HYPODERMIC NEEDLE MARKET – COUNTRY ANALYSIS
15.1. Europe Disposable Hypodermic Needle Market Overview by Country Segment
15.1.1. Europe Disposable Hypodermic Needle Market Revenue Share By Region
15.2. Europe
15.2.1. Europe Disposable Hypodermic Needle Market Revenue By Country
15.2.2. Type
15.2.3. Europe Disposable Hypodermic Needle Market Revenue By Type
15.2.4. Material
15.2.5. Europe Disposable Hypodermic Needle Market Revenue By Material
15.2.6. End-user Industry
15.2.7. Europe Disposable Hypodermic Needle Market Revenue By End-user Industry
15.2.8. Application
15.2.9. Europe Disposable Hypodermic Needle Market Revenue By Application
15.2.10. Distribution Channel
15.2.11. Europe Disposable Hypodermic Needle Market Revenue By Distribution Channel
15.3. UK
15.4. France
15.5. Germany
15.6. Italy
15.7. Spain
15.8. Russia
15.9. Rest of Europe CHAPTER NO. 16 : ASIA PACIFIC DISPOSABLE HYPODERMIC NEEDLE MARKET – COUNTRY ANALYSIS
16.1. Asia Pacific Disposable Hypodermic Needle Market Overview by Country Segment
16.1.1. Asia Pacific Disposable Hypodermic Needle Market Revenue Share By Region
16.2. Asia Pacific
16.2.1. Asia Pacific Disposable Hypodermic Needle Market Revenue By Country
16.2.2. Type
16.2.3. Asia Pacific Disposable Hypodermic Needle Market Revenue By Type
16.2.4. Material
16.2.5. Asia Pacific Disposable Hypodermic Needle Market Revenue By Material
16.2.6. End-user Industry
16.2.7. Asia Pacific Disposable Hypodermic Needle Market Revenue By End-user Industry
16.2.8. Application
16.2.9. Asia Pacific Disposable Hypodermic Needle Market Revenue By Application
16.2.10. Distribution Channel
16.2.11. Asia Pacific Disposable Hypodermic Needle Market Revenue By Distribution Channel
16.3. China
16.4. Japan
16.5. South Korea
16.6. India
16.7. Australia
16.8. Southeast Asia
16.9. Rest of Asia Pacific CHAPTER NO. 17 : LATIN AMERICA DISPOSABLE HYPODERMIC NEEDLE MARKET – COUNTRY ANALYSIS
17.1. Latin America Disposable Hypodermic Needle Market Overview by Country Segment
17.1.1. Latin America Disposable Hypodermic Needle Market Revenue Share By Region
17.2. Latin America
17.2.1. Latin America Disposable Hypodermic Needle Market Revenue By Country
17.2.2. Type
17.2.3. Latin America Disposable Hypodermic Needle Market Revenue By Type
17.2.4. Material
17.2.5. Latin America Disposable Hypodermic Needle Market Revenue By Material
17.2.6. End-user Industry
17.2.7. Latin America Disposable Hypodermic Needle Market Revenue By End-user Industry
17.2.8. Application
17.2.9. Latin America Disposable Hypodermic Needle Market Revenue By Application
17.2.10. Distribution Channel
17.2.11. Latin America Disposable Hypodermic Needle Market Revenue By Distribution Channel
17.3. Brazil
17.4. Argentina
17.5. Rest of Latin America CHAPTER NO. 18 : MIDDLE EAST DISPOSABLE HYPODERMIC NEEDLE MARKET – COUNTRY ANALYSIS
18.1. Middle East Disposable Hypodermic Needle Market Overview by Country Segment
18.1.1. Middle East Disposable Hypodermic Needle Market Revenue Share By Region
18.2. Middle East
18.2.1. Middle East Disposable Hypodermic Needle Market Revenue By Country
18.2.2. Type
18.2.3. Middle East Disposable Hypodermic Needle Market Revenue By Type
18.2.4. Material
18.2.5. Middle East Disposable Hypodermic Needle Market Revenue By Material
18.2.6. End-user Industry
18.2.7. Middle East Disposable Hypodermic Needle Market Revenue By End-user Industry
18.2.8. Application
18.2.9. Middle East Disposable Hypodermic Needle Market Revenue By Application
18.2.10. Distribution Channel
18.2.11. Middle East Disposable Hypodermic Needle Market Revenue By Distribution Channel
18.3. GCC Countries
18.4. Israel
18.5. Turkey
18.6. Rest of Middle East CHAPTER NO. 19 : AFRICA DISPOSABLE HYPODERMIC NEEDLE MARKET – COUNTRY ANALYSIS
19.1. Africa Disposable Hypodermic Needle Market Overview by Country Segment
19.1.1. Africa Disposable Hypodermic Needle Market Revenue Share By Region
19.2. Africa
19.2.1. Africa Disposable Hypodermic Needle Market Revenue By Country
19.2.2. Type
19.2.3. Africa Disposable Hypodermic Needle Market Revenue By Type
19.2.4. Material
19.2.5. Africa Disposable Hypodermic Needle Market Revenue By Material
19.2.6. End-user Industry
19.2.7. Africa Disposable Hypodermic Needle Market Revenue By End-user Industry
19.2.8. Application
19.2.9. Africa Disposable Hypodermic Needle Market Revenue By Application
19.2.10. Distribution Channel
19.2.11. Africa Disposable Hypodermic Needle Market Revenue By Distribution Channel
19.3. South Africa
19.4. Egypt
19.5. Rest of Africa CHAPTER NO. 20 : COMPANY PROFILES
20.1. Zhejiang Jinghuan
20.1.1. Company Overview
20.1.2. Product Portfolio
20.1.3. Financial Overview
20.1.4. Recent Developments
20.1.5. Growth Strategy
20.1.6. SWOT Analysis
20.2. Forlong Medical
20.3. Carl Stuart Group
20.4. ISCON SURGICALS LTD.
20.5. Dynarex
20.6. Air-Tite
20.7. Narang Medical
20.8. TERUMO
20.9. Merck
20.10. Accutome Inc.
20.11. TENKO MEDICAL
20.12. Vitrex Medical
Request A Free Sample
We prioritize the confidentiality and security of your data. Our promise: your information remains private.
Ready to Transform Data into Decisions?
Request Your Sample Report and Start Your Journey of Informed Choices
Providing the strategic compass for industry titans.
Frequently Asked Questions
What is the current market size for Disposable Hypodermic Needle Market, and what is its projected size in 2032?
The Disposable Hypodermic Needle Market was valued at USD 6,306.76 million in 2024 and is projected to reach USD 9,539.97 million by 2032.
At what Compound Annual Growth Rate is the Disposable Hypodermic Needle Market projected to grow between 2024 and 2032?
The Disposable Hypodermic Needle Market is projected to grow at a CAGR of 5.38% during the forecast period.
Which Disposable Hypodermic Needle Market segment held the largest share in 2024?
In 2024, hospitals held the largest share of the Disposable Hypodermic Needle Market due to high patient volumes and procedure rates.
What are the primary factors fueling the growth of the Disposable Hypodermic Needle Market?
The Disposable Hypodermic Needle Market growth is fueled by rising chronic diseases, increased surgeries, strict infection control, and adoption of safety-engineered devices.
Who are the leading companies in the Disposable Hypodermic Needle Market?
Key players in the Disposable Hypodermic Needle Market include Zhejiang Jinghuan, Forlong Medical, Terumo, Merck, Dynarex, and Narang Medical.
Which region commanded the largest share of the Disposable Hypodermic Needle Market in 2024?
North America commanded the largest share of the Disposable Hypodermic Needle Market in 2024, driven by advanced healthcare systems and regulatory frameworks.
About Author
Shweta Bisht
Healthcare & Biotech Analyst
Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.
Global Circular Staplers Market size was valued at USD 626.2 million in 2018 to USD 1,064.3 million in 2024 and is anticipated to reach USD 2,209.7million by 2032, at a CAGR of 9.62% during the forecast period.
Global Balloon Dilators Market size was valued at USD 1,544.2 million in 2018 to USD 2,221.7million in 2024 and is anticipated to reach USD 3,898.4 million by 2032, at a CAGR of 7.31 % during the forecast period.
The Mobile Gamma Cameras Market size was valued at USD 58.7 million in 2024 and is anticipated to reach USD 70.5 million by 2032, at a CAGR of 3.19% during the forecast period (2024-2032).
High Tibial Osteotomy HTO Plates Market size was valued at USD 227.8 million in 2024 and is anticipated to reach USD 310.76 million by 2032, at a CAGR of 4% during the forecast period.
Guillain Barre Syndrome Diagnostics Market size was valued at USD 139.53 million in 2024 and is anticipated to reach USD 173.03 million by 2032, at a CAGR of 2.8% during the forecast period.
The market for Inferior Vena Cava (IVC) filters is projected to grow from USD 878.72 million in 2024 to USD 1,765.16 million by 2032, reflecting a compound annual growth rate (CAGR) of 8.49%.
The Handheld X-Rays Market was valued at USD 1,680.5 million in 2024 and is projected to reach USD 3,610.2 million by 2032, expanding at a CAGR of 10.03% during the forecast period.
The gamma knife market size was valued at USD 458.22 million in 2024 and is anticipated to reach USD 686.38 million by 2032, at a CAGR of 5.2 % during the forecast period (2024-2032).
The Global Kinesiology Tapes Market size was valued at USD 154.7 million in 2018 to USD 267.2 million in 2024 and is anticipated to reach USD 482.1 million by 2032, at a CAGR of 7.56% during the forecast period.
The healthcare 3D printing market size was valued at USD 10.09 billion in 2024 and is expected to reach USD 38.69 billion by 2032, growing at a CAGR of 18.3% during the forecast period.
Internal Trauma Fixation Devices Market size was valued at USD 7.79 Billion in 2024 and is projected to reach USD 11.16 Billion by 2032, growing at a CAGR of 4.6% during the forecast period.
General Surgery Devices Market size was valued at USD 18.39 billion in 2024 and is anticipated to reach USD 34.8 billion by 2032, at a CAGR of 8.3% during the forecast period.
Licence Option
The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999
To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999
The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.
Materials Scientist (privacy requested)
The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.
Market Trends:
Segmentation:
